Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas

Leuk Res. 2014 Sep;38(9):1003. doi: 10.1016/j.leukres.2014.08.013. Epub 2014 Aug 23.
No abstract available

Publication types

  • Congress

MeSH terms

  • Drug Resistance, Neoplasm
  • Hodgkin Disease / metabolism
  • Hodgkin Disease / therapy
  • Humans
  • Ki-1 Antigen / metabolism*
  • Lymphoma / metabolism*
  • Lymphoma / therapy*
  • Lymphoma, Large-Cell, Anaplastic / metabolism
  • Lymphoma, Large-Cell, Anaplastic / therapy
  • Molecular Targeted Therapy / methods*
  • Molecular Targeted Therapy / trends*
  • Recurrence

Substances

  • Ki-1 Antigen